Synopsis: Healing from the Inside Out: The Microbiome Gut-Brain Axis and Minority Mental Health
- Rachelle DiMedia
- Aug 21
- 7 min read
By Rachelle DiMedia
Introduction
Most people are unaware of the intricate connection between the gut and brain, known as the gut-brain axis (also referred to as the microbiome-gut-brain axis or GBA). Gut bacteria play a crucial role in mood, stress levels, and mental disorders like depression and anxiety, via the GBA. Disturbances in the balance between gut bacteria, known as dysbiosis, cause dysregulation of the bidirectional pathways between the gut and brain, leading to a wide array of neurological and gastrointestinal (GI) disorders. The GBA is a sophisticated system of communication that scientists are only now beginning to comprehend. It is essential to understand how this affects your body and mind to achieve optimal health. However, as new science emerges and breakthroughs occur, is this information and care available to everyone? Even now, despite advances in medicine, technology, and transportation, access to proper education, food, and medical care is limited for many minority populations. What can be done to address this and ensure access for all?
In recent years, psychobiotics—a subset of probiotics—have gained attention as potential treatments that could reduce symptoms of anxiety and depression by targeting the gut microbiome. This groundbreaking area of medicine could reshape how we view and treat mental health, particularly for minority populations who often face systemic barriers to care.
The Gut-Brain Superhighway
The gut is home to trillions of microorganisms—collectively called the microbiome—which produce neurotransmitters such as:
Serotonin (up to 90% produced in the gut)
GABA
Cortisol regulators
These microbes influence mood, cognition, stress response, and even behavior. When the microbiome is out of balance (dysbiosis), negative signals take over, impacting brain areas connected to aggression, irritability, depression, decision-making, and impulse control.
What Are Psychobiotics?
Coined in 2013, psychobiotics refer to live microorganisms that provide mental health benefits. They work by:
Modulating neurotransmitters like serotonin and GABA,
Lowering pro-inflammatory cytokines, and
Regulating the HPA axis to reduce stress response.
Though still under study, psychobiotics offer a low-risk, non-pharmacologic option for improving overall mental health, especially when combined with diet and lifestyle changes.
Promising Strains and Early Results
Animal and human studies have shown several strains to be particularly effective:
Bifidobacterium longum: Reduces anxiety and cortisol, improves memory and sleep quality.
Lacticaseibacillus rhamnosus: Beneficial for postpartum depression when administered prenatally and postnatally.
Lactobacillus helveticus + B. longum: Combination shown to enhance emotional regulation, especially when paired with healthy behaviors like physical activity, diet, and nature exposure.
Microbial byproducts like short-chain fatty acids (SCFAs) have also demonstrated anti-anxiety effects when delivered directly to the colon.
Minority Mental Health: A Crisis Amplified
Studies suggest that socioeconomic status, dietary habits, and access to healthy food all affect the microbiome, potentially exacerbating mood disorders in underserved communities.
Mental illness affects people of all backgrounds, but Black, Indigenous, and People of Color (BIPOC) often face unique challenges. People experiencing discrimination due to race, gender, religion, disability, sexual orientation, or socioeconomic status are exposed to negative environments and chronic stress, which leads to an altered GBA, putting them at risk for mental and physical disease:
Inflammation
Cognitive, memory, and learning impairment
Poor impulse and inhibition control, especially in stressful situations
Poor coping mechanisms to deregulate from distress
Obesity
Cravings for hyperpalatable, high-calorie, low-nutrient foods (UPFs) and sweets
Poor impulse control
Anxiety, depression, bipolar disorder, ASD, ADHD, schizophrenia, and other mental and emotional disorders
Altered pain responses: For example, visceral sensitivity, which is an increased sensitivity to pain in the internal organs, with a lower pain threshold, often leading to chronic pain
Altered regulatory functions in the brain that are critical for adapting to internal or external challenges, but also trigger emotion, decision making, and promote social behavior
Altered brain networks related to:
Emotion, causing heightened responses in: emotion regulation, alertness (hypervigilance), attention toward certain stimuli, and autonomic responses
Cognition
Self-perception
Pain-related processing
Barriers to Clinical Translation
Despite early promise, psychobiotics haven’t yet entered mainstream psychiatric practice due to:
Inconsistent study designs and small sample sizes
Lack of standardized tools to assess emotional outcomes (e.g., mindfulness, stress resilience)
Difficulty in modeling psychiatric conditions in animals
· Wide variability in individual microbiomes
Psychobiotic research must include more diverse populations to ensure equitable solutions and prevent further marginalization. Standardization and diversity are essential for future research to succeed.
Legal and Ethical Implications
The reach of the microbiome goes beyond medicine. In rare cases like Auto-brewery Syndrome, gut bacteria ferment carbohydrates into alcohol, raising blood alcohol levels without drinking. Such cases have had legal consequences, including DUI dismissals.
Understanding the microbiome’s role in behavioral control could one day influence fields like forensic psychiatry and criminal justice.
Looking Forward
Key strategies include:
Culturally Inclusive Nutrition Education – Providing accessible information on gut-friendly diets tailored to cultural preferences.
Community-Based Mental Health Programs – Expanding mental health services that integrate dietary and lifestyle interventions.
Policy Changes to Address Food Deserts – Advocating for better access to nutritious foods in underserved areas.
· Reducing Discrimination-Related Stress – Implementing stress management programs to mitigate the physiological effects of discrimination.
· Inclusion of psychobiotics in therapeutic regimens to attain optimal GBA health: We are on the edge of a new era where mental health may be healed from the inside out. Psychobiotics are not a replacement for therapy or medication, but they could:
Complement existing treatments,
Empower individuals through diet and lifestyle, and
Offer preventive strategies to at-risk populations
For this to succeed, we must:
Make research more inclusive
Study environmental and cultural factors that affect the microbiome
Integrate nutrition, psychology, and social justice into care models
Conclusion
The gut-brain axis (GBA) has been recognized for centuries, but only recently have we begun to understand its complexities. There is a need for safe, effective therapies that can complement existing treatments to improve patient outcomes. Modern research shows that diseases arise from interconnected systems rather than isolated factors, highlighting the importance of a holistic approach. As we learn how the microbiome influences health, significant investments are being made to modulate the GBA for treating various diseases, including mental, metabolic, and digestive disorders. Understanding how societal issues like discrimination and chronic stress activate the GBA is crucial.
Maintaining GBA balance is vital for digestive and mental health. Microbiome imbalances contribute to many diseases, and advances in microbial classification, AI, and gene sequencing are paving the way for novel therapies like biotics. The gut-brain communication is increasingly studied, but individual microbiome differences pose challenges for personalized treatment and biomarker discovery. Knowledge about this communication could enable early disease detection and intervention, potentially slowing neurodegenerative progression and mitigating environmental stress effects.
However, more research is needed on how societal stressors activate the GBA. Future opportunities include new treatments and preventive services accessible to all, emphasizing the importance of equitable healthcare. Addressing these issues is essential for ensuring everyone has the chance to lead a healthy life.
Psychobiotics have enormous potential to transform mental health care, especially for underserved populations. By leveraging the microbiome-gut-brain connection, we can reduce suffering and target root causes, ensuring the benefits reach everyone, not just the privileged.
References:
Sasso JM, Ammar RM, Tenchov R, Lemmel S, Kelber O, Grieswelle M, and Qiongqiong Zhou QA.Gut Microbiome–Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders. ACS Chem Neurosc. 2023;14(10): 1717-1763.
DOI: 10.1021/acschemneuro.3c00127
Crompton S (2019) Psychobiotics: your microbiome has the potential to improve your mental health, not just your gut health. Science focus. https://www.sciencefocus.com/the-human-body/psychobiotics-your-microbiom. Accessed: June 17, 2025.
Xiong RG, Li J, Cheng J, Zhou DD, Wu SX, Huang SY, Saimaiti A, Yang ZJ, Gan RY, Li HB. The Role of Gut Microbiota in Anxiety, Depression, and Other Mental Disorders as Well as the Protective Effects of Dietary Components. Nutrients. 2023 Jul 23;15(14):3258. doi: 10.3390/nu15143258. PMID: 37513676; PMCID: PMC10384867.
Merlo G, Bachtel G, Sugden SG. Gut microbiota, nutrition, and mental health. Front Nutr. 2024 Feb 9;11:1337889. doi: 10.3389/fnut.2024.1337889. PMID: 38406183; PMCID: PMC10884323.
Tuhin,M. How Your Gut Health Affects Your Brain: The Mind-altering Power of Your Microbiome. Science News Today.2025 May 17. thttps://www.sciencenewstoday.org/how-your-gut-health-affects-your-brain-the-mind-altering-power-of-your-microbiome#google_vignette
Ji J, Jin W, Liu SJ, Jiao Z, Li X. Probiotics, prebiotics, and postbiotics in health and disease. MedComm (2020). 2023 Nov 4;4(6):e420. doi: 10.1002/mco2.420. PMID: 37929014; PMCID: PMC10625129.
Sharma R, Gupta D, Mehrotra R, Mago P. Psychobiotics: The Next-Generation Probiotics for the Brain. Curr Microbiol. 2021 Feb;78(2):449-463. doi: 10.1007/s00284-020-02289-5. Epub 2021 Jan 4. PMID: 33394083.
Zhang, X., Wang, H., Kilpatrick, L.A. et al. Discrimination exposure impacts unhealthy processing of food cues: crosstalk between the brain and gut. Nat. Mental Health 1, 841–852 (2023). https://doi.org/10.1038/s44220-023-00134-9.
Dong TS, Gee GC, Beltran-Sanchez H, Wang M, Osadchiy V, Kilpatrick LA, Chen Z, Subramanyam V, Zhang Y, Guo Y, Labus JS, Naliboff B, Cole S, Zhang X, Mayer EA, Gupta A. How Discrimination Gets Under the Skin: Biological Determinants of Discrimination Associated With Dysregulation of the Brain-Gut Microbiome System and Psychological Symptoms. Biol Psychiatry. 2023 Aug 1;94(3):203-214. doi: 10.1016/j.biopsych.2022.10.011. Epub 2022 Oct 28. PMID: 36754687; PMCID: PMC10684253.
Paton SEJ, Solano JL, Coulombe-Rozon F, Lebel M, Menard C. Barrier-environment interactions along the gut-brain axis and their influence on cognition and behaviour throughout the lifespan. J Psychiatry Neurosci. 2023 May 30;48(3):E190-E208. doi: 10.1503/jpn.220218. PMID: 37253482; PMCID: PMC10234620.
Chen S, Yu W, Shen Y, Lu L, Meng X, Liu J. Unraveling the mechanisms underlying air pollution-induced dysfunction of the oral-gut-brain axis: implications for human health and well-being. Asian Biomed (Res Rev News). 2025 Feb 28;19(1):21-35. doi: 10.2478/abm-2025-0002. PMID: 40231163; PMCID: PMC11994223.
Mehta I, Juneja K, Nimmakayala T, Bansal L, Pulekar S, Duggineni D, Ghori HK, Modi N, Younas S. Gut Microbiota and Mental Health: A Comprehensive Review of Gut-Brain Interactions in Mood Disorders. Cureus. 2025 Mar 30;17(3):e81447. doi: 10.7759/cureus.81447. PMID: 40303511; PMCID: PMC12038870.
Rathore K, Shukla N, Naik S, Sambhav K, Dange K, Bhuyan D, Imranul Haq QM. The Bidirectional Relationship Between the Gut Microbiome and Mental Health: A Comprehensive Review. Cureus. 2025 Mar 19;17(3):e80810. doi: 10.7759/cureus.80810. PMID: 40255763; PMCID: PMC12007925.
Son MY, Cho HS. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers. J Microbiol Biotechnol. 2023 Jul 28;33(7):849-856. doi: 10.4014/jmb.2301.01031. Epub 2023 Mar 30. PMID: 37100764; PMCID: PMC10394342.
Franck, M., Tanner, K.T., Tennyson, R.L. et al. Nonuniversality of inflammaging across human populations. Nat Aging (2025). https://doi.org/10.1038/s43587-025-00888-0.
Author: Rachelle DiMedia
Comments